Skip Nav Destination
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components
Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia
Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease
Issue Archive
May 14 2024
In this Issue
Table of Contents
INSIDE BLOOD ADVANCES
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis
Clinical Trials & Observations
Geffen Kleinstern,Nicholas J. Boddicker,Daniel R. O’Brien,Cristine Allmer,Kari G. Rabe,Aaron D. Norman,Rosalie Griffin,Huihuang Yan,Tao Ma,Timothy G. Call,Laura Bruins,Sochilt Brown,Cecilia Bonolo de Campos,Curtis A. Hanson,Jose F. Leis,Wei Ding,Celine M. Vachon,Neil E. Kay,Christopher C. Oakes,Alexander S. Parker,Danielle M. Brander,J. Brice Weinberg,Richard R. Furman,Tait D. Shanafelt,James R. Cerhan,Sameer A. Parikh,Esteban Braggio,Susan L. Slager
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia
Clinical Trials & Observations
Regina M. Myers,Kaitlin Devine,Yimei Li,Sophie Lawrence,Allison Barz Leahy,Hongyan Liu,Lauren Vernau,Colleen Callahan,Diane Baniewicz,Stephan Kadauke,Regina McGuire,Gerald B. Wertheim,Irina Kulikovskaya,Vanessa E. Gonzalez,Joseph A. Fraietta,Amanda M. DiNofia,Stephen P. Hunger,Susan R. Rheingold,Richard Aplenc,Carl H. June,Stephan A. Grupp,Lisa Wray,Shannon L. Maude
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab
Clinical Trials & Observations
Shanmuganathan Chandrakasan,Michael B. Jordan,Ashley Baker,Edward M. Behrens,Deepika Bhatla,May Chien,Olive S. Eckstein,Michael M. Henry,Michelle L. Hermiston,Ashley P. Hinson,Jennifer W. Leiding,Abiola Oladapo,Sachit A. Patel,Priti Pednekar,Anish K. Ray,Blachy Dávila Saldaña,Susmita N. Sarangi,Kelly J. Walkovich,John D. Yee,Adi Zoref-Lorenz,Carl E. Allen,on behalf of the REAL-HLH Investigators
HEALTH SERVICES AND OUTCOMES
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
Clinical Trials & Observations
Sara Carrillo de Albornoz,Alisa M. Higgins,Dennis Petrie,Adam Irving,Laura Fanning,Robert Weinkove,Philip Crispin,Claire Dendle,Michael Gilbertson,Anna Johnston,Anastazia Keegan,Dominic Pepperell,Humphrey Pullon,John Reynolds,Tina van Tonder,Judith Trotman,Neil Waters,Cameron Wellard,Helen Weston,C. Orla Morrissey,Erica M. Wood,Zoe K. McQuilten
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile
Zhihong Zeng,Annelies Roobrouck,Geert Deschamps,Helene Bonnevaux,Stephane Guerif,Veronique De Brabandere,Céline Amara,Eline Dejonckheere,Angela Virone-Oddos,Marielle Chiron,Marina Konopleva,Melissa Dullaers
LYMPHOID NEOPLASIA
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study
Clinical Trials & Observations
Laura Samples,Jenna Voutsinas,Bita Fakhri,Sirin Khajavian,Stephen Spurgeon,Deborah Stephens,Alan Skarbnik,Anthony Mato,Catherine Broome,Ajay Gopal,Stephen Smith,Ryan Lynch,Magdalena Rainey,Myung Sun Kim,Odeth Barrett-Campbell,Emily Hemond,Mazie Tsang,Daniel Ermann,Nikita Malakhov,Danielle Rao,Mehrdad Shakib-Azar,Beth Morrigan,Ayushi Chauhan,Thomas Plate,Ted Gooley,Kellie Ryan,Frederick Lansigan,Brian Hill,Georgios Pongas,Sameer A. Parikh,Lindsey Roeker,John N. Allan,Richard Cheng,Chaitra Ujjani,Mazyar Shadman
EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome
Seiichi Kato,Motoharu Hamada,Akinao Okamoto,Daisuke Yamashita,Hiroaki Miyoshi,Haruto Arai,Akira Satou,Yuka Gion,Yasuharu Sato,Yuta Tsuyuki,Tomoko Miyata-Takata,Katsuyoshi Takata,Naoko Asano,Emiko Takahashi,Koichi Ohshima,Akihiro Tomita,Waki Hosoda,Shigeo Nakamura,Yusuke Okuno
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
Clinical Trials & Observations
Kurt S. Bantilan,Alexandra N. Smith,Matthew J. Maurer,Julie Teruya-Feldstein,Matthew J. Matasar,Alison J. Moskowitz,David J. Straus,Ariela Noy,M. Lia Palomba,Steven M. Horwitz,Paul A. Hamlin,Carol S. Portlock,James R. Cerhan,Thomas M. Habermann,Gilles A. Salles,Grzegorz S. Nowakowski,Craig H. Moskowitz,Andrew D. Zelenetz
MYELOID NEOPLASIA
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia
Katherine Tarlock,Robert B. Gerbing,Rhonda E. Ries,Jenny L. Smith,Amanda Leonti,Benjamin J. Huang,Danielle Kirkey,Leila Robinson,Jack H. Peplinksi,Beverly Lange,Todd M. Cooper,Alan S. Gamis,E. Anders Kolb,Richard Aplenc,Jessica A. Pollard,Todd A. Alonzo,Soheil Meshinchi
PLASMA CELL DISORDERS
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma
Clinical Trials & Observations
Coty Hing Yau Cheung,Chi Keung Cheng,Kam Tong Leung,Chi Zhang,Chi Yan Ho,Xi Luo,Angel Yuet Fong Kam,Tian Xia,Thomas Shek Kong Wan,Herbert Augustus Pitts,Natalie Pui Ha Chan,Joyce Sin Cheung,Raymond Siu Ming Wong,Xiao-Bing Zhang,Margaret Heung Ling Ng
THROMBOSIS AND HEMOSTASIS
Interactions between integrin α9β1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVT
Nilesh Pandey,Harpreet Kaur,Mehul R. Chorawala,Sumit Kumar Anand,Lakshmi Chandaluri,Megan E. Butler,Richa Aishwarya,Shiva J. Gaddam,Xinggui Shen,Mabruka Alfaidi,Jian Wang,Xiaolu Zhang,Kavitha Beedupalli,Md. Shenuarin Bhuiyan,Mohammad Alfrad Nobel Bhuiyan,Prabandh Buchhanolla,Prashant Rai,Rahul Shah,Himanshu Chokhawala,J. Dedrick Jordan,Tarek Magdy,A. Wayne Orr,Karen Y. Stokes,Oren Rom,Nirav Dhanesha
TRANSFUSION MEDICINE
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components
Clinical Trials & Observations
Allison P. Wheeler,Edward L. Snyder,Majed Refaai,Claudia S. Cohn,Jessica Poisson,Magali Fontaine,Mary Sehl,Ajay K. Nooka,Lynne Uhl,Philip C. Spinella,Maly Fenelus,Darla Liles,Thomas Coyle,Joanne Becker,Michael Jeng,Eric A. Gehrie,Bryan R. Spencer,Pampee Young,Andrew Johnson,Jennifer J. O’Brien,Gary J. Schiller,John D. Roback,Elizabeth Malynn,Ronald Jackups,Scott T. Avecilla,Kathy Liu,Stanley Bentow,Jeanne Varrone,Richard J. Benjamin,Laurence M. Corash
TRANSPLANTATION
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract
Zachariah DeFilipp,Ashish V. Damania,Haesook T. Kim,Chia-Chi Chang,Areej El-Jawahri,Steven L. McAfee,AJ S. Bottoms,Vesselina Toncheva,Melissa M. Smith,Maria Dolaher,Lindsey Perry,Meghan White,Brittany Diana,Sheila Connolly,Bimalangshu R. Dey,Matthew J. Frigault,Richard A. Newcomb,Paul V. O’Donnell,Thomas R. Spitzer,Michael K. Mansour,Daniela Weber,Nadim J. Ajami,Elizabeth Hohmann,Robert R. Jenq,Yi-Bin Chen
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT
Claus-Philipp Maier,Chihab Klose,Christian Martin Seitz,Florian Heubach,Michaela Döring,Roland Meisel,Friedhelm Schuster,Bernd Gruhn,Frieder Keller,Armin Rabsteyn,Anne-Marie Arendt,Germano Amorelli,Thomas Eichholz,Tobias Feuchtinger,Holger Martinius,Stefan Nierkens,Rouwen Teltschik,Johannes Hubertus Schulte,Claudia Lengerke,Rupert Handgretinger,Peter Lang
RESEARCH LETTERS
Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia
Clinical Trials & Observations
Kris Richardson,Jorge J. Castillo,Shayna R. Sarosiek,Andrew R. Branagan,Catherine A. Flynn,Kirsten Meid,Joshua N. Gustine,Xia Liu,Amanda Kofides,Shirong Liu,Julie L. Wolf,Katherine A. Kacena,Christopher J. Patterson,Maria Luisa Guerrera,Nicholas Tsakmaklis,Steven P. Treon,Zachary R. Hunter
Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease
Clinical Trials & Observations
COMMENTARY
ERRATA
-
Cover Image
Cover Image
Predicted α9β1 structure with an inhibitor using homology modeling. The homology modeling approach was used to build the atomistic model. The crystal structure of α4β1 (Protein Data Bank code 3V4P) was used to model the α9 subunit. The aligned model was superimposed on α4β1, and the coordinates of β1 along with divalent ions Ca2+ and Mg2+ were extracted and merged with the α9 subunit to make a full complex of α9β1. The final model was thoroughly optimized to remove the steric clashes. See the article by Pandey et al.
Advertisement intended for health care professionals
Advertisement intended for health care professionals